Sign in to view content

Outcomes of Antivascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice

Andrew A. Moshfeghi, MD, MBA, FASRS

Video
Published 2018

Related

Pharmacokinetic Profile of the Port Delivery System With Ranibizumab: From PRN Refills in Phase 2 Ladder to Fixed 24-Week Refills In Phase 3 Archway
Dilsher S. Dhoot, MD
Annual Meeting Talks
2020
Peripheral Findings in Macular Telangiectasis Type 2
Stavros N Moysidis, M.D.
Annual Meeting Talks
2018
Episode 131: Journal Club on Follow-up for AMD and PDR Patients, Phase II and III Clinical Trials, Ophthalmology Chairs in the U.S. with Dr. M. Ali Khan
Jayanth Sridhar, MD
Member Podcasts
2018

Category: Age-Related Macular Degeneration

See more